Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD

Clinical trial NCT07132398 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07132398
Sponsor: Tianjin Medical University General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neuromyelitis Optica (NMO)Neuromyelitis Optica Spectrum Disorders (NMOSD)

Start date: 2025-09-01
Primary completion: 2027-08-31
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.